HOME >> BIOLOGY >> NEWS
Duke Researchers Discover Candidate Susceptibility Gene For Autoimmune Disease

ls that had similar clinical signs, the researchers hypothesized the animals were producing too much of a potent inflammatory protein called tumor necrosis factor alpha (TNFa).
To test their idea, the researchers injected the TTP-deficient animals with an antibody that neutralizes TNFa. In a dramatic and almost complete reversal, all signs of disease completely disappeared.

The findings support preliminary results of human clinical trials being conducted at Duke and other research institutions of an experimental treatment for rheumatoid arthritis (RA) that also uses antibodies to TNFa, Blackshear said. Such studies have shown antibodies to TNFa can significantly reduce the symptoms of RA in patients.

"We know that TNFa is involved in many human inflammatory diseases including autoimmune disorders and septic shock," Blackshear said. "This finding provides insight into a new gene that appears to regulate TNFa. It is possible that defects in this gene may cause people to be susceptible to developing autoimmune diseases."

The corresponding gene has been identified in people, and Blackshear's group will soon begin a study to see if mutations in the gene correlate with autoimmune disease in people.

"The TTP-deficient mouse is an exciting new model of arthritis," said Haynes, chairman of medicine at Duke and director of the Duke University Arthritis Center. "It also provides important new information about the types of genes that can cause arthritis."

In addition to using the animal model to understand the autoimmune response, Blackshear will continue studies to determine how TTP is involved in the insulin response.

"Right now we really don't have a good handle on what TTP is doing, although there are hints it is involved in gene regulation," Blackshear said. "Our next step will be to determine if it is involved in synthesis or degradation of TNF_ and then move forward to our original question of how TTP i
'"/>

Contact: Karyn Hede George
georg016@mc.duke.edu
919-660-1301
Duke University
14-May-1996


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... UK (PRWEB) , ... December 08, 2016 , ... ... precision light to control cells — optogenetics — is key to exciting advances ... of the art, spatially patterned light projected via free-space optics stimulates small, transparent ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), The Molecular ... with the launch of the SureSeq myPanel™ NGS Custom FH ... familial hypercholesterolemia (FH). The panel delivers single nucleotide variation (SNV) ... panel and allows customisation by ,mix and match, of fully-optimised ... LDLR , P C SK9 , ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... and commercializing products to treat rare diseases where ... the long-term follow-up data from its Phase 2 ... Defense Regulator (IDR), in the treatment of oral ... undergoing chemoradiation therapy (CRT).  The additional 12-month safety ...
Breaking Biology Technology:
Cached News: